Three Peaks Capital Management Decreased Stake in Allegion Pub LTD Co (ALLE) by $5.84 Million; Johnson & Johnson (JNJ) Stock Price Rose While Toron Capital Markets Has Boosted Holding

November 14, 2017 - By Richard Conner

Toron Capital Markets Inc increased its stake in Johnson & Johnson (JNJ) by 1.8% based on its latest 2017Q2 regulatory filing with the SEC. Toron Capital Markets Inc bought 3,175 shares as the company’s stock rose 6.85% with the market. The institutional investor held 179,139 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $23.70M, up from 175,964 at the end of the previous reported quarter. Toron Capital Markets Inc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $373.69 billion market cap company. The stock declined 0.47% or $0.66 reaching $139.1 on the news. About 339,317 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since November 14, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Three Peaks Capital Management Llc decreased its stake in Allegion Pub Ltd Co (ALLE) by 44.88% based on its latest 2017Q2 regulatory filing with the SEC. Three Peaks Capital Management Llc sold 72,038 shares as the company’s stock rose 7.90% with the market. The institutional investor held 88,459 shares of the diversified commercial services company at the end of 2017Q2, valued at $7.18 million, down from 160,497 at the end of the previous reported quarter. Three Peaks Capital Management Llc who had been investing in Allegion Pub Ltd Co for a number of months, seems to be less bullish one the $7.92B market cap company. The stock declined 0.69% or $0.58 reaching $83.35 per share. About 52,704 shares traded. Allegion PLC (NYSE:ALLE) has risen 17.63% since November 14, 2016 and is uptrending. It has outperformed by 0.93% the S&P500.

Investors sentiment increased to 1.11 in Q2 2017. Its up 0.13, from 0.98 in 2017Q1. It increased, as 39 investors sold ALLE shares while 101 reduced holdings. 51 funds opened positions while 104 raised stakes. 81.02 million shares or 1.60% less from 82.34 million shares in 2017Q1 were reported. Wesbanco Fincl Bank has 0.03% invested in Allegion PLC (NYSE:ALLE). Gemmer Asset Mngmt Limited Liability accumulated 0% or 130 shares. Clifford Swan Invest Counsel Ltd Liability stated it has 0.02% in Allegion PLC (NYSE:ALLE). Caisse De Depot Et Placement Du Quebec owns 3,300 shares. Dekabank Deutsche Girozentrale has 0.09% invested in Allegion PLC (NYSE:ALLE) for 141,128 shares. Utah Retirement Sys has 17,465 shares. Pcj Invest Counsel accumulated 13,440 shares or 0.07% of the stock. Parsons Cap Management Incorporated Ri has invested 0.03% in Allegion PLC (NYSE:ALLE). Cibc accumulated 13,454 shares. Da Davidson stated it has 1,732 shares. Williams Jones Assoc Limited Liability Corp reported 1.07 million shares. Commonwealth Bancorporation Of Aus reported 0% in Allegion PLC (NYSE:ALLE). Global X Mngmt Limited Com holds 0% or 739 shares in its portfolio. Td Asset reported 194,063 shares. Alliancebernstein Limited Partnership has invested 0.1% in Allegion PLC (NYSE:ALLE).

Three Peaks Capital Management Llc, which manages about $566.27 million and $678.09M US Long portfolio, upped its stake in Ardagh Group S A by 53,336 shares to 282,774 shares, valued at $6.39 million in 2017Q2, according to the filing. It also increased its holding in Extended Stay Amer Inc (NYSE:STAY) by 232,042 shares in the quarter, for a total of 646,166 shares, and has risen its stake in Engility Hldgs Inc New (NYSE:EGL).

Analysts await Allegion PLC (NYSE:ALLE) to report earnings on February, 8. They expect $0.93 EPS, up 14.81% or $0.12 from last year’s $0.81 per share. ALLE’s profit will be $88.37 million for 22.41 P/E if the $0.93 EPS becomes a reality. After $1.02 actual EPS reported by Allegion PLC for the previous quarter, Wall Street now forecasts -8.82% negative EPS growth.

Among 11 analysts covering Allegion PLC (NYSE:ALLE), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. Allegion PLC had 27 analyst reports since August 3, 2015 according to SRatingsIntel. Bank of America maintained Allegion PLC (NYSE:ALLE) rating on Thursday, July 20. Bank of America has “Buy” rating and $91 target. The company was downgraded on Tuesday, August 2 by Imperial Capital. Imperial Capital downgraded the shares of ALLE in report on Thursday, November 5 to “In-Line” rating. The stock has “Outperform” rating by Bernstein on Tuesday, January 19. Robert W. Baird maintained Allegion PLC (NYSE:ALLE) on Thursday, October 26 with “Hold” rating. Robert W. Baird maintained it with “Hold” rating and $88.0 target in Monday, September 25 report. On Friday, May 5 the stock rating was maintained by Imperial Capital with “Outperform”. The firm has “Buy” rating by CLSA given on Friday, February 12. The company was maintained on Wednesday, October 18 by Wells Fargo. As per Wednesday, September 23, the company rating was initiated by Credit Suisse.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 13 have Buy rating, 5 Sell and 5 Hold. Therefore 57% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Hold” rating by Piper Jaffray given on Monday, October 2. The company was maintained on Tuesday, June 14 by Jefferies. The rating was maintained by Jefferies on Friday, July 14 with “Hold”. Atlantic Securities downgraded the shares of JNJ in report on Friday, July 21 to “Sell” rating. The rating was maintained by Morgan Stanley with “Equal-Weight” on Wednesday, October 18. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Cowen & Co on Thursday, August 24. As per Friday, December 18, the company rating was initiated by Atlantic Securities. The stock has “Buy” rating by UBS on Tuesday, September 22. The rating was maintained by RBC Capital Markets on Wednesday, October 7 with “Outperform”. As per Wednesday, August 2, the company rating was maintained by BTIG Research.

Investors sentiment decreased to 0.83 in 2017 Q2. Its down 0.03, from 0.86 in 2017Q1. It fall, as 50 investors sold JNJ shares while 878 reduced holdings. 105 funds opened positions while 667 raised stakes. 1.73 billion shares or 0.03% less from 1.73 billion shares in 2017Q1 were reported. Eagle Ridge Inv has 26,594 shares. S R Schill And Associates has 0.87% invested in Johnson & Johnson (NYSE:JNJ). Cibc Asset Mngmt invested in 367,044 shares. Cap Ltd Limited Liability Corporation holds 1,456 shares or 0.07% of its portfolio. Daniel Devine invested in 4.02% or 37,207 shares. Harding Loevner Lp, a New Jersey-based fund reported 800 shares. Indiana & Inv Management Co invested in 0.91% or 14,022 shares. Df Dent & Com Inc holds 86,325 shares. Pinnacle Wealth Mgmt Advisory Gru Ltd Limited Liability Company stated it has 1.95% in Johnson & Johnson (NYSE:JNJ). Forbes J M Communications Ltd Liability Partnership reported 93,358 shares. 7,654 were accumulated by Fin Ptnrs Capital Mngmt Limited Company. 306,331 were accumulated by Amalgamated Comml Bank. Eubel Brady Suttman Asset Mgmt accumulated 134,891 shares or 5.44% of the stock. Cetera Advisor Lc accumulated 152,003 shares. 11,083 are owned by Orrstown Incorporated.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Cnbc.com which released: “Johnson & Johnson CEO reveals the leadership lessons he learned at West Point” on November 11, 2017, also Seekingalpha.com with their article: “Johnson & Johnson Pipeline Impresses” published on November 06, 2017, Cnbc.com published: “Johnson & Johnson CEO: Washington needs to work with us for ‘smart tax policy'” on November 09, 2017. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Prnewswire.com and their article: “Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to …” published on November 13, 2017 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson: Not Overvalued Per FCF Standpoint” with publication date: November 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

Twitter Auto Publish Powered By : XYZScripts.com